Showing results (1-10 of 212) with videos related to

Sort By:
Pageof 22
Clinical Lymphoma, Myeloma & Leukemia|July 15, 2014
Thrombosis and hemostatic abnormalities in hematological malignanciesRiccardo Colombo, Paolo Gallipoli, Roberto Castelli
Annals of Hematology|April 9, 2014
Biosimilar epoetin in elderly patients with low-risk myelodysplastic syndromes improves anemia, quality of life, and brain functionRoberto Castelli, Giorgio Lambertenghi Deliliers, Riccardo Colombo, et al.
Journal of Thrombosis and Thrombolysis|October 13, 2017
High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutationRoberto Castelli, Paolo Gallipoli, Riccardo Schiavon, et al.
Clinical Chemistry and Laboratory Medicine|January 27, 2016
Laboratory and clinical risk assessment to treat myelodysplatic syndromesAntonio Gidaro, Giorgio Lambertenghi Deliliers, Paolo Gallipoli, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 9, 2020
Does Outcome/Survival of Patients With Myelodysplastic Syndromes Should Be Predicted by Reduced Levels of ADAMTS-13? Results From a Pilot StudyRoberto Castelli, Luigi Bergamaschini, Thomas Teatini, et al.
Anti-Cancer Drugs|August 22, 2015
Salvage therapy with bortezomib and dexamethasone in elderly patients with relapsed/refractory multiple myelomaRoberto Castelli, Giuseppe Pantaleo, Paolo Gallipoli, et al.
Frontiers in Oncology|June 7, 2021
The Role of Metabolism in the Development of Personalized Therapies in Acute Myeloid LeukemiaVilma Dembitz, Paolo Gallipoli
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 4, 2018
Prognostic Models Turn the Heat(IT)up on FLT3ITD -Mutated AMLPaolo Gallipoli, Brian J P Huntly
Seminars in Cancer Biology|August 8, 2017
Novel epigenetic therapies in hematological malignancies: Current status and beyondPaolo Gallipoli, Brian J P Huntly
Pageof 22